Enrique Gallardo

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer

Elena Castro, Nuria Romero-Laorden, Ángela del Pozo et al. · Journal of Clinical Oncology · 2019 · 366 citations · Full text

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy

Joaquim Bellmunt, Luis Paz‐Ares, Mauricio Cuello et al. · Annals of Oncology · 2007 · 315 citations · Full text

Urology, Oncology, Cisplatin-based Chemotherapy +9

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani et al. · Annals of Oncology · 2017 · 263 citations · Full text

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

John C. Araujo, Géralyn C. Trudel, Fred Saad et al. · The Lancet Oncology · 2013 · 229 citations · Full text

Double-blind Phase 3, Urology, Genitourinary Cancer +6

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

Jesús García-Donás, Emilio Esteban, Luis J. Leandro‐García et al. · The Lancet Oncology · 2011 · 220 citations

Urology, Genitourinary Cancer, Medicine +7